28 related articles for article (PubMed ID: 12710527)
21. Direct Estimation of CaV1.2 Gating Parameters: Quantification of Voltage Sensor - Pore Transductions and their Modulation by FLP 64176.
Stanislav B; Philipp K; Eugen T; Steffen H
Curr Mol Pharmacol; 2015; 8(1):87-94. PubMed ID: 25966699
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte calcium signaling involves dihydropyridine-sensitive L-type calcium channels: facts and controversies.
Gomes B; Savignac M; Moreau M; Leclerc C; Lory P; Guery JC; Pelletier L
Crit Rev Immunol; 2004; 24(6):425-47. PubMed ID: 15777162
[TBL] [Abstract][Full Text] [Related]
23. Dissecting the functional role of different isoforms of the L-type Ca2+ channel.
Bourinet E; Mangoni ME; Nargeot J
J Clin Invest; 2004 May; 113(10):1382-4. PubMed ID: 15146233
[TBL] [Abstract][Full Text] [Related]
24. Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
Chahine M; Sculptoreanu A; Varma DR
Can J Physiol Pharmacol; 2003 Feb; 81(2):135-41. PubMed ID: 12710527
[TBL] [Abstract][Full Text] [Related]
25. Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets.
Abernethy DR; Soldatov NM
J Pharmacol Exp Ther; 2002 Mar; 300(3):724-8. PubMed ID: 11861774
[TBL] [Abstract][Full Text] [Related]
26. Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
Ohashi N; Mitamura H; Ogawa S
Drugs; 2009; 69(1):21-30. PubMed ID: 19192934
[TBL] [Abstract][Full Text] [Related]
27. 1,4-Dihydropyridine activators and antagonists: structural and functional distinctions.
Triggle DJ; Rampe D
Trends Pharmacol Sci; 1989 Dec; 10(12):507-11. PubMed ID: 2694544
[TBL] [Abstract][Full Text] [Related]
28. L-type calcium channels.
Triggle DJ
Curr Pharm Des; 2006; 12(4):443-57. PubMed ID: 16472138
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
